The Apex Times
Above the Noise
Business Wire
BusinessGoldman Sachs and JPMorgan Chase both raise dividends, prompting fresh debate over which large bank offers the better valueThe Apex TimesBusinessNike stock’s sharp underperformance is drawing fresh bullish arguments, but details remain thinThe Apex TimesBusinessModerna’s Phase 3 cancer vaccine win and Nasdaq-100 inclusion highlight shift toward oncologyThe Apex TimesBusinessLeidos (LDOS) wins $56 million Naval Health Research Center award and extends UK defence logistics workThe Apex TimesBusinessDefense Stocks Watch: RTX Adds Counter-Drone Business as AeroVironment Announces International Deals and Palantir Moves With New AI VentureThe Apex TimesBusinessNavy C-130J-30 Delivery Points to Continued Progress for Lockheed’s TACAMO Mission, Investors Watch for Follow-ThroughThe Apex TimesBusinessMastercard pushes a stablecoin-ready payments “switchboard,” aiming to make crypto rails easier for banksThe Apex TimesBusinessLockheed Martin’s missile backlog and new PAC-3 Edge interceptor add momentum as investors weigh valuationThe Apex TimesBusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex TimesBusinessGoldman Sachs and JPMorgan Chase both raise dividends, prompting fresh debate over which large bank offers the better valueThe Apex TimesBusinessNike stock’s sharp underperformance is drawing fresh bullish arguments, but details remain thinThe Apex TimesBusinessModerna’s Phase 3 cancer vaccine win and Nasdaq-100 inclusion highlight shift toward oncologyThe Apex TimesBusinessLeidos (LDOS) wins $56 million Naval Health Research Center award and extends UK defence logistics workThe Apex TimesBusinessDefense Stocks Watch: RTX Adds Counter-Drone Business as AeroVironment Announces International Deals and Palantir Moves With New AI VentureThe Apex TimesBusinessNavy C-130J-30 Delivery Points to Continued Progress for Lockheed’s TACAMO Mission, Investors Watch for Follow-ThroughThe Apex TimesBusinessMastercard pushes a stablecoin-ready payments “switchboard,” aiming to make crypto rails easier for banksThe Apex TimesBusinessLockheed Martin’s missile backlog and new PAC-3 Edge interceptor add momentum as investors weigh valuationThe Apex TimesBusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex TimesBusinessGoldman Sachs and JPMorgan Chase both raise dividends, prompting fresh debate over which large bank offers the better valueThe Apex TimesBusinessNike stock’s sharp underperformance is drawing fresh bullish arguments, but details remain thinThe Apex TimesBusinessModerna’s Phase 3 cancer vaccine win and Nasdaq-100 inclusion highlight shift toward oncologyThe Apex TimesBusinessLeidos (LDOS) wins $56 million Naval Health Research Center award and extends UK defence logistics workThe Apex TimesBusinessDefense Stocks Watch: RTX Adds Counter-Drone Business as AeroVironment Announces International Deals and Palantir Moves With New AI VentureThe Apex TimesBusinessNavy C-130J-30 Delivery Points to Continued Progress for Lockheed’s TACAMO Mission, Investors Watch for Follow-ThroughThe Apex TimesBusinessMastercard pushes a stablecoin-ready payments “switchboard,” aiming to make crypto rails easier for banksThe Apex TimesBusinessLockheed Martin’s missile backlog and new PAC-3 Edge interceptor add momentum as investors weigh valuationThe Apex TimesBusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex TimesBusinessGoldman Sachs and JPMorgan Chase both raise dividends, prompting fresh debate over which large bank offers the better valueThe Apex TimesBusinessNike stock’s sharp underperformance is drawing fresh bullish arguments, but details remain thinThe Apex TimesBusinessModerna’s Phase 3 cancer vaccine win and Nasdaq-100 inclusion highlight shift toward oncologyThe Apex TimesBusinessLeidos (LDOS) wins $56 million Naval Health Research Center award and extends UK defence logistics workThe Apex TimesBusinessDefense Stocks Watch: RTX Adds Counter-Drone Business as AeroVironment Announces International Deals and Palantir Moves With New AI VentureThe Apex TimesBusinessNavy C-130J-30 Delivery Points to Continued Progress for Lockheed’s TACAMO Mission, Investors Watch for Follow-ThroughThe Apex TimesBusinessMastercard pushes a stablecoin-ready payments “switchboard,” aiming to make crypto rails easier for banksThe Apex TimesBusinessLockheed Martin’s missile backlog and new PAC-3 Edge interceptor add momentum as investors weigh valuationThe Apex TimesBusinessEli Lilly investors who bought in 2025 focused on what the company implied, even as the stock outpaced the broader marketThe Apex TimesBusinessTSMC warns AI chip demand still outpaces supply, reigniting focus on Nvidia’s role in the buildoutThe Apex TimesBusinessBlackRock Investors Weigh How Private Markets and Active ETFs Could Change Fee StreamsThe Apex TimesBusinessMag 7 roundup spotlights Tesla Roadster timeline, Nvidia’s “space AI” push and Microsoft’s Nadella security warningThe Apex Times
Back to front
Yahoo Finance highlights bullish case for Lockheed Martin, citing a Substack thesis on long-term value
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jun 29, 4:02 PM EDT

Yahoo Finance highlights bullish case for Lockheed Martin, citing a Substack thesis on long-term value

A Yahoo Finance market piece reviewed arguments from Compounding Lab’s Substack suggesting Lockheed Martin (LMT) could be attractive for investors, though the specific financial metrics and assumptions discussed were not provided in the available excerpt.

By The Apex Times Newsroom2 min readAI-assisted Apex article

Yahoo Finance published a market-news article on June 29, 2026, addressing whether Lockheed Martin Corporation, trading under the ticker LMT on the NYSE, is a “good stock to buy now.” The article’s stated purpose was to summarize a bullish thesis presented by Compounding Lab on its Substack, indicating a focus on longer-term reasoning rather than a single near-term catalyst.

In the write-up, Yahoo Finance frames Lockheed Martin as the company at the center of the discussion, but the available information here does not include the detailed claims or the quantitative support behind the bullish view. As a result, this report can only confirm that the Yahoo Finance piece is a summary of that external thesis, not the thesis itself.

Compounding Lab’s Substack is described by Yahoo Finance as the originating source of the arguments. The Yahoo Finance article does not, in the information provided, identify specific program wins, contract values, earnings estimates, or valuation multiples that would normally be used to substantiate a “buy” case.

Lockheed Martin operates in the Defense sector, an industry where stock performance commonly tracks government procurement priorities, program execution, and the pace of follow-on contracts. For investors, the practical question is usually whether management can reliably convert backlog and awarded work into revenue and cash flow over time.

Defense contractors also face a recurring tension between long acquisition cycles and the need to fund production and technology development before outcomes become visible. In that context, bullish theses often lean on durability of demand and the ability to manage cost and schedule, but those specific points are not included in the available excerpt from the Yahoo Finance article.

Because the detailed thesis content is not present here, readers should treat any specific conclusions about LMT’s valuation, growth outlook, margin trajectory, or risk profile as unresolved until the original Compounding Lab post and the full Yahoo Finance article can be reviewed directly.

One practical next step is to compare what the bullish thesis claims against Lockheed Martin’s own disclosures about contracts, delivery performance, and segment or program updates. The company’s official news releases page can be used to verify whether there were recent contract announcements or progress updates that align with the bullish narrative.

What to watch next for this debate is whether the thesis relies on measurable drivers that Lockheed can substantiate in its investor-facing communications, such as new awards, changes to backlog, production and delivery milestones, or guidance-related commentary. If those disclosures do not align with the thesis assumptions, the market case could weaken.

Why It Matters

  • Summaries of third-party “buy now” theses can influence how retail investors frame risk and time horizons, even when the underlying assumptions are not fully reproduced in headlines or short excerpts.
  • Defense-sector performance often depends on program execution and procurement cycles, making it important to verify whether any bullish claims map to observable company disclosures.
  • When the detailed thesis rationale is not available in the coverage, investors and readers should treat conclusions as unverified until the full primary arguments are reviewed.
  • The most reliable cross-check for any bullish defense narrative is whether company-released contract and program updates support the timeline and drivers being claimed.

Sources

Key Facts

  • Yahoo Finance published a June 29, 2026 article asking whether Lockheed Martin Corporation (LMT) is a good stock to buy now.
  • The Yahoo Finance piece says it summarizes a bullish thesis from Compounding Lab’s Substack.
  • The available excerpt does not provide the detailed thesis arguments, metrics, or assumptions that the bullish case uses.
  • Lockheed Martin is identified in the source as a Defense-sector company with shares trading under the ticker LMT on the NYSE.
  • No specific contract figures, earnings estimates, or valuation levels are included in the available information for this review.

Defense Related

Yahoo Finance highlights bullish case for Lockheed Martin, citing a Substack thesis on long-term value | The Apex Times